Mycobacterial Caseinolytic Protease Gene Regulator ClgR Is a Substrate of Caseinolytic Protease
ABSTRACT The mycobacterial caseinolytic protease ClpP1P2 is a degradative protease that recently gained interest as a genetically and pharmacologically validated drug target for tuberculosis. The first whole-cell active ClpP1P2 inhibitor, the human proteasome inhibitor bortezomib, is currently under...
Enregistré dans:
Auteurs principaux: | Yoshiyuki Yamada, Thomas Dick |
---|---|
Format: | article |
Langue: | EN |
Publié: |
American Society for Microbiology
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/bd664c524a7b41c0ab4868df940839d7 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Technical data on the inhibition properties of some medicinal plant extracts towards caseinolytic protease proteolytic subunit of Plasmodium knowlesi
par: Raimalynah Abd Razak, et autres
Publié: (2021) -
Synthetic Gene-Based Heterologous Expression, Proteolytic, and Structural Characterization of Caseinolytic Protease of Lactobacillus plantarum IIA-1A5
par: M. Yusuf, et autres
Publié: (2021) -
Target Mechanism-Based Whole-Cell Screening Identifies Bortezomib as an Inhibitor of Caseinolytic Protease in Mycobacteria
par: Wilfried Moreira, et autres
Publié: (2015) -
Type VII Secretion Substrates of Pathogenic Mycobacteria Are Processed by a Surface Protease
par: Maroeska J. Burggraaf, et autres
Publié: (2019) -
Protease Inhibitor and Metabolic Alteration
par: Cavenaghi,F. M, et autres
Publié: (2012)